Testicular Cancer - Results from #180

REVIEW UroToday

Conditional survival of stage III non-seminoma testis cancer patients. August 11, 2023

The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey. August 10, 2023

Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors. August 7, 2023

Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy. August 7, 2023

Organ-Sparing Surgery for Testicular Germ Cell Tumors: A Current Perspective. August 4, 2023

Impact of testicular cancer on sperm small non-coding RNA signature: a pilot study. August 2, 2023

Sexual function using the EORTC QLQ-TC26 in testicular cancer survivors: A multi-institutional, cross-sectional study. July 31, 2023

Onco-TESE (Testicular Sperm Extraction): Insights from a Tertiary Center and Comprehensive Literature Analysis. July 31, 2023

Post-chemotherapy robot-assisted retroperitoneal lymph node dissection for metastatic germ cell tumors: safety and perioperative outcomes. July 30, 2023

Exceedingly Rare Bilateral Synchronous Germ Cell Testicular Tumors With Different Histopathological Features. July 27, 2023

Malignant testicular tumors in children: overview on 10 years of Saudi Cancer Registry. July 24, 2023

Metastatic Testicular Cancer Patterns and Predictors: A Contemporary Population-Based SEER Analysis. July 20, 2023

A Nested Case-Control Study of Serum Per- and Polyfluoroalkyl Substances and Testicular Germ Cell Tumors among U.S. Air Force Servicemen. July 19, 2023

High-intensity interval training and thromboembolic events during chemotherapy for testicular cancer: a retrospective analysis from the Body & Cancer cohort. July 17, 2023

Large-scale Sequencing of Testicular Germ Cell Tumour (TGCT) Cases Excludes Major TGCT Predisposition Gene. July 14, 2023

Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors. July 14, 2023

Resection of Residual Masses After Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumors in Adolescents and Adults. July 10, 2023

Guideline of Guidelines: Follow-up After Orchiectomy for Clinical Stage I Testicular Cancer. July 7, 2023

Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment. July 3, 2023

Imaging Techniques to Differentiate Benign Testicular Masses from Germ Cell Tumors. June 28, 2023

Page 10 of 94